Fundraising Fox
Boson Ventures
Venture capitalMelbourne · Pre-Seed–Series A · 10 people tracked
Find your way into Boson Ventures
Sign up to see every warm intro you have to Boson Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Boson Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Boson Ventures targets Australian deep-tech founders building defensible IP across bio and medical, advanced manufacturing, AI and robotics, and climate and energy. It argues that despite Australia's world-class research output and 15 Nobel laureates, the country has historically failed to capture commercial upside as science and talent migrate abroad. The firm sees the 2020-2027 window — supported by the A$15B National Reconstruction Fund and a scarcity of active deep-tech VCs — as an entry point before valuations rise. Its stated edge lies in deep technical due diligence and a direct Greater China commercialisation corridor. Investments are ESVCLP-eligible and limited to Australian-registered companies.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & curated
Former corporate finance and M&A specialist at AstraZeneca and Philips, with a decade in asset management as Managing Director of Hong Kong's largest multi-family office, and a healthcare angel investor.
Experienced healthcare investor and early backer of several listed Chinese biotechs, who has managed cross-border venture capital and global hedge funds in healthcare and TMT.
Inventor of one of only two FDA-approved small-molecule drugs originating from Australia. Founder & CEO of SYNthesis Med Chem, former Chief Business Officer and EVP at Viva Biotech, and co-inventor of 16+ drug patents.
A veteran venture capital investor with a global track record across Australia, Israel, the US, and China, and notable blockchain/web3 wins including STEPN. He is also founding partner of Follow [The] Seed, Imprint Capital Partners, and Welinder & Shi Capital.
Former founder with two successful exits and ex-managing director of Workmate, an operating partner at Workplace Accelerator and former VP at ING, as well as a global keynote speaker and angel investor.
Co-founder and former Chief Scientist of a listed company and Board Director of BioNSW, recognized for developing a national diagnostics development strategy.
Former CEO of an ASX-listed additive manufacturing firm and CEO of Grey Innovation, a Non-Executive Director in European biotech, and former SVP of biopharma in Europe who led US expansion.
Co-founder of a climate tech company that reached A$12M revenue growth in under four years without external funding, and Head of Strategic Partnership at AGL New Energy.
Former partner and Managing Director of Accenture Strategy Greater China, and previously Vice President of Investment Banking at Morgan Stanley in Japan.
What they invest in
from 6 of 11 portfolio companiesSaaS ×4Advanced Manufacturing ×2Digital Health ×2Enterprise Software ×2Healthtech ×2AI & Machine Learning ×1Cleantech ×1Construction Tech ×1
HQs:Australia×3Switzerland×1
Investments · 11 tracked
founders shown can be your intro pathAI-NC offers a browser-based tool that reviews mechanical product designs for manufacturability, flagging issues such as unmachinable features, tolerance problems, and changes between revisions before parts reach production.
Advanced ManufacturingAI & Machine LearningSaaS
Co-investorsFlying Fox VenturesMelbourne Accelerator Program (MAP)Omni VenturesStartmate Launch Club
Catalyser provides a platform for corporate social responsibility and employee engagement, combining workplace giving, volunteering coordination, and AI-driven personalization to help companies and their employees increase community impact.
Enterprise SoftwareFuture of WorkHR TechImpact & Social GoodSaaS
Co-investorsScalare Partners
Clever.Care builds the Clever.Care Coordinator, a messenger-style communication and coordination platform for home care providers, their clients, relatives, and third-party providers such as pharmacies and physicians.
Digital HealthHealthtechSaaSBasel, CH
Andres Rapp(Co-Founder)in
Co-investorsKickstart InnovationBessemer Venture PartnersCrossFundCultivation CapitalFloodgateGV (Google Ventures)+4 more
Fiable provides financial viability assessments and vendor risk evaluation services for construction contractors and main contractors assessing supply chain delivery risk.
Construction TechData & InfrastructureEnterprise SoftwareFintechLegalTechSaaSAustralia, AU
Patrick Connolly(Founder)
Kite Magnetics develops Aeroperm®, a nanocrystalline magnetic material that improves electric motor efficiency, targeting automotive powertrains and unmanned aerial vehicle propulsion systems.
Advanced ManufacturingCleantechDeep TechEnergyHardwareNew MaterialsVictoria, AU
Richard Parsons(Founder and CEO)inKiyonori Suzuki(Professor)Liz Williams(Senior Executive)in
Co-investorsBreakthrough VictoriaBlackbird VenturesGalileo VenturesInvestible Climate Tech FundPossible VenturesSQM Lithium Ventures
Osara Health (formerly CancerAid) provides evidence-based education, support and behavior-change programs for people impacted by cancer, including patients and caregivers, with the aim of improving clinical outcomes such as quality of life, physical and mental health, and survival rates.
Digital HealthHealthtechWellness & Fitness
Raghav Murali-Ganesh(Founder)in
Co-investorsArchangel VenturesClinton Capital Partners
Modern publishing platform for independent media; wound down in 2024.
Co-investorsShearwater CapitalStartmate Launch ClubStartmate
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Clarity PharmaceuticalHello CleverJunshi BioLoop+
Portfolio news
latest coverage across their companies
Catalyser · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- How many investments has Boson Ventures made?
- Boson Ventures has 11 tracked investments.
- What stage does Boson Ventures invest at?
- Boson Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Boson Ventures focus on?
- Boson Ventures focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Energy, Medical Devices, Robotics.
- Where is Boson Ventures located?
- Boson Ventures is headquartered in Melbourne, AU.
- Does Boson Ventures lead rounds?
- Yes, Boson Ventures leads investment rounds.
- Who does Boson Ventures co-invest with?
- Boson Ventures most often shares deals with Startmate Launch Club, Blackbird Ventures, Clinton Capital Partners, among 13 tracked co-investors.
Similar investors
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Yu Galaxy is a Silicon Valley venture capital firm that invests early and leads rounds, backing technologies addressing fundamental constraints on human progress across energy, health, intelligence, manufacturing, infrastructure, and national security.
HCVC is a venture capital firm that backs founders working to industrialize scientific and technological progress across deep tech, robotics, and hard science domains.
Freeflow (Freeflow Ventures) is an early-stage venture firm investing in science-driven, deep tech companies emerging from the Caltech and Berkeley research communities.
MaRS Discovery District is Canada's anchor innovation hub, based in Toronto, that supports startups and scale-ups with commercialization guidance, connections to capital, customers and talent, and access to a network of advisors, researchers and partners.